403 related articles for article (PubMed ID: 31615089)
21. Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity.
Yuan L; Bing Z; Yan P; Li R; Wang C; Sun X; Yang J; Shi X; Zhang Y; Yang K
Gene; 2019 Oct; 716():144025. PubMed ID: 31394177
[TBL] [Abstract][Full Text] [Related]
22. High expression levels of miR-21 and miR-210 predict unfavorable survival in breast cancer: a systemic review and meta-analysis.
Tang Y; Zhou X; Ji J; Chen L; Cao J; Luo J; Zhang S
Int J Biol Markers; 2015 Nov; 30(4):e347-58. PubMed ID: 26349663
[TBL] [Abstract][Full Text] [Related]
23. Prognostic Value of MicroRNAs in Stage II Colorectal Cancer Patients: A Systematic Review and Meta-Analysis.
Sabarimurugan S; Madhav MR; Kumarasamy C; Gupta A; Baxi S; Krishnan S; Jayaraj R
Mol Diagn Ther; 2020 Feb; 24(1):15-30. PubMed ID: 32020560
[TBL] [Abstract][Full Text] [Related]
24. Prognostic Value of miRNAs in Head and Neck Cancers: A Comprehensive Systematic and Meta-Analysis.
Kumarasamy C; Madhav MR; Sabarimurugan S; Krishnan S; Baxi S; Gupta A; Gothandam KM; Jayaraj R
Cells; 2019 Jul; 8(8):. PubMed ID: 31349668
[TBL] [Abstract][Full Text] [Related]
25. The prognostic and therapeutic application of microRNAs in breast cancer: Tissue and circulating microRNAs.
Bahrami A; Aledavood A; Anvari K; Hassanian SM; Maftouh M; Yaghobzade A; Salarzaee O; ShahidSales S; Avan A
J Cell Physiol; 2018 Feb; 233(2):774-786. PubMed ID: 28109133
[TBL] [Abstract][Full Text] [Related]
26. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
Hu Y; Xu K; Yagüe E
Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794
[TBL] [Abstract][Full Text] [Related]
27. miRNAs as therapeutic predictors and prognostic biomarkers of neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis.
Zhang Z; Zhang H; Yu J; Xu L; Pang X; Xiang Q; Liu Q; Cui Y
Breast Cancer Res Treat; 2022 Aug; 194(3):483-505. PubMed ID: 35727379
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic value of circulating microRNAs as biomarkers for breast cancer: a meta-analysis study.
Cui Z; Lin D; Song W; Chen M; Li D
Tumour Biol; 2015 Feb; 36(2):829-39. PubMed ID: 25296735
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Significance of FOXC1 in Various Cancers: A Systematic Review and Meta-Analysis.
Sabapathi N; Sabarimurugan S; Madurantakam Royam M; Kumarasamy C; Xu X; Xu G; Jayaraj R
Mol Diagn Ther; 2019 Dec; 23(6):695-706. PubMed ID: 31372939
[TBL] [Abstract][Full Text] [Related]
30. Circulating MicroRNAs as Prognostic Molecular Biomarkers in Human Head and Neck Cancer: A Systematic Review and Meta-Analysis.
Lamichhane SR; Thachil T; Gee H; Milic N
Dis Markers; 2019; 2019():8632018. PubMed ID: 31827646
[TBL] [Abstract][Full Text] [Related]
31. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Value of Expression of MicroRNAs in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
Zhan B; Lu D; Luo P; Wang B
Clin Lab; 2016 Nov; 62(11):2203-2211. PubMed ID: 28164670
[TBL] [Abstract][Full Text] [Related]
33. The Role of MicroRNAs in Diagnosis, Prognosis, Metastasis and Resistant Cases in Breast Cancer.
Teoh SL; Das S
Curr Pharm Des; 2017; 23(12):1845-1859. PubMed ID: 28231756
[TBL] [Abstract][Full Text] [Related]
34. A Clinical Investigation on the Theragnostic Effect of MicroRNA Biomarkers for Survival Outcome in Cervical Cancer: A PRISMA-P Compliant Protocol for Systematic Review and Comprehensive Meta-Analysis.
Shaw P; Senthilnathan R; Sankar S; Ilangovan I; Kodiveri Muthukaliannan G; Baxi S; Mani RR; Rajagopal M; Chinnappan S; Balaraman AK; Suresh D; Krishnan S; Gupta M; Muthusamy T; Paranjothy C; Jayaraj R
Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328017
[TBL] [Abstract][Full Text] [Related]
35. Detection of human papillomavirus in lung cancer: systematic review and meta-analysis.
Syrjänen K
Anticancer Res; 2012 Aug; 32(8):3235-50. PubMed ID: 22843898
[TBL] [Abstract][Full Text] [Related]
36. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.
Krishnan P; Ghosh S; Wang B; Li D; Narasimhan A; Berendt R; Graham K; Mackey JR; Kovalchuk O; Damaraju S
BMC Genomics; 2015 Sep; 16():735. PubMed ID: 26416693
[TBL] [Abstract][Full Text] [Related]
37. Role of microRNAs in Predicting the Prognosis of Cervical Cancer Cases: A Systematic Review and Meta-Analysis.
Sabeena S; Ravishankar N
Asian Pac J Cancer Prev; 2021 Apr; 22(4):999-1006. PubMed ID: 33906290
[TBL] [Abstract][Full Text] [Related]
38. The Role of MicroRNAs in the Chemoresistance of Breast Cancer.
Wang J; Yang M; Li Y; Han B
Drug Dev Res; 2015 Nov; 76(7):368-74. PubMed ID: 26310899
[TBL] [Abstract][Full Text] [Related]
39. Suppression of SPIN1-mediated PI3K-Akt pathway by miR-489 increases chemosensitivity in breast cancer.
Chen X; Wang YW; Xing AY; Xiang S; Shi DB; Liu L; Li YX; Gao P
J Pathol; 2016 Aug; 239(4):459-72. PubMed ID: 27171498
[TBL] [Abstract][Full Text] [Related]
40. MiRNA signature predicts the response of patients with advanced lung adenocarcinoma to platinum-based treatment.
Xu X; Yu S; Sun W; Qin X; Chen Y; Zhou L; Lou R; Dong S; Shen B; Wu J; Zang J; Cao H; Shi M; Zhang Q; Feng J
J Cancer Res Clin Oncol; 2018 Mar; 144(3):431-438. PubMed ID: 29288364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
